The study, led by Associate Professor Jacques Behmoaras and first author Dr. Harry Park from the Centre of Biomedical Data Science, utilized single-cell RNA sequencing data to map the genetic activity of immune cells across the entire human lifespan. The cohort included individuals aged 19 to 97, with a diverse demographic composition that included a significant number of participants of Asian ethnicity. This large-scale integration of publicly available research datasets allowed the team to create a comprehensive immune atlas, offering a high-resolution view of how the immune system evolves over time. The analysis focused on the transcriptomic profiles of various immune cell types, particularly T cells, which are central to coordinating the body’s defense mechanisms against pathogens.

The researchers discovered that the fundamental machinery responsible for cellular function, specifically the genes involved in the synthesis of RNA and proteins, experiences its most pronounced decline during two specific windows: around age 40 and again after age 60. These periods represent critical inflection points where the immune system undergoes rapid reorganization. Rather than a steady erosion of capacity, the data suggests that the immune system undergoes abrupt changes in gene expression patterns. This nonlinear trajectory implies that the body’s immune resilience is not simply lost bit by bit, but rather that specific functional capacities are compromised at distinct life stages, potentially leaving individuals more vulnerable to specific types of immune dysregulation during these periods.

T cells emerged as the primary drivers of these nonlinear changes. The study found that T cells, a type of white blood cell essential for fighting infections, showed the most significant alterations in gene activity during the first wave around age 40. This early shift likely reflects the central role T cells play in coordinating the immune response and their heightened sensitivity to the initial effects of aging. Interestingly, the specific subtypes of T cells that undergo profound changes at age 40 are different from those that drive the second wave of changes after age 60. This distinction suggests that T cells have specialized roles at different stages of life, and that the aging process affects these specialized functions in a staggered manner.

One of the most significant findings of the study is the identification of sex-specific differences in immune aging trajectories. While both men and women experience the two major waves of immune aging, the specific patterns of gene activity and the types of T cells involved differ between the sexes. These differences may help explain why women are more likely than men to develop autoimmune diseases, such as lupus and rheumatoid arthritis, despite generally living longer. In Singapore alone, more than 600,000 people, or about 11 percent of the population, suffer from autoimmune conditions. The study suggests that the immune system’s response to aging is not uniform, and that sex-specific biological pathways may predispose individuals to different types of immune-related disorders at different stages of life.

Professor Antonio Bertoletti, a co-author of the study and a leader in the Emerging Infectious Diseases Signature Research Programme at Duke-NUS, emphasized the importance of understanding these nonlinear changes. He noted that previous evidence had suggested T cells are among the immune cells most affected by aging, but the new study provides a detailed map of how and when these changes occur. Understanding the specific biological pathways that drive these shifts could help explain why older adults are more susceptible to infections and inflammatory conditions. The findings suggest that interventions aimed at boosting immune function may need to be timed to coincide with these critical windows of vulnerability to be most effective.

To further explore the implications of these findings, the scientists developed artificial intelligence models capable of predicting biological age based on the immune cell data. Biological age is an estimation of the ‘true age’ of the body, which can differ from chronological age. By using these AI models, researchers can identify individuals whose immune systems are aging faster or slower than their peers. This tool could be used to tailor preventive strategies and treatments based on an individual’s biological age and sex, moving away from a one-size-fits-all approach to aging. The ability to predict biological age from immune cell profiles opens up new possibilities for personalized medicine, where treatments can be adjusted to match the specific needs of a patient’s immune system.

The study was conducted in collaboration with several Signature Research Programmes at Duke-NUS, including those in Cardiovascular and Metabolic Disorders, Cancer and Stem Cell Biology, and Emerging Infectious Diseases. Partners from the NUS Yong Loo Lin School of Medicine also contributed to the research. Professor Sheemei Lok, Duke-NUS’ Interim Vice-Dean for Research, highlighted the significance of the findings for the field of aging research. She stated that the study provides a more detailed map of how the human immune system changes across the lifespan, and importantly, how those trajectories differ between men and women. This knowledge is fundamental for developing precise approaches to maintaining health as people grow older, rather than relying on generalized strategies that may not account for individual biological differences.

The research was supported by the National Research Foundation, Singapore, and the National Medical Research Council, underscoring the importance of this work in the context of Singapore’s healthcare landscape. The findings have broad implications for global health, as the patterns of immune aging observed in this diverse cohort are likely to be relevant to other populations. By identifying the specific windows of immune vulnerability and the sex-specific differences in these trajectories, the study provides a foundation for future research into targeted interventions. Understanding the nonlinear nature of immune aging could lead to the development of therapies that are more effective at preventing or treating age-related immune disorders, ultimately improving the quality of life for older adults.

As the global population ages, the need for a deeper understanding of the biological mechanisms underlying age-related diseases becomes increasingly urgent. This study represents a significant step forward in that effort, providing a new perspective on how the immune system changes over time. By revealing the distinct waves of immune aging and the sex-specific differences in these trajectories, the researchers have opened up new avenues for investigation and intervention. The findings suggest that the future of aging research lies in a more nuanced, personalized approach that takes into account the complex, nonlinear dynamics of the immune system. This work not only advances our scientific understanding but also holds promise for improving clinical outcomes for patients suffering from immune-related diseases.

Subject of Research: Nonlinear trajectories of sex-specific immune aging at the single-cell level

Article Title: Immune ageing accelerates around 40 and 60, with key differences between men and women

Article References: Immune ageing accelerates around 40 and 60, with key differences between men and women. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Immune Aging, Single-Cell RNA Sequencing, T Cells, Autoimmune Diseases, Sex-Specific Differences, Biological Age, Genome Activity, Duke-NUS Medical School, Nature Communications, Nonlinear Aging, Personalized Medicine, Immune Atlas